IQV
IQVIA Holdings Inc
NYSE: IQV · HEALTHCARE · DIAGNOSTICS & RESEARCH
$158.37
+1.09% today
Updated 2026-04-30
Market cap
$26.30B
P/E ratio
20.01
P/S ratio
1.61x
EPS (TTM)
$7.83
Dividend yield
—
52W range
$135 – $247
Volume
1.8M
IQVIA Holdings Inc (IQV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.34%
Operating margin
15.20%
ROE
21.40%
ROA
5.05%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $3.92B | $160.60M | 28.52% | 10.07% | 4.09% |
| 2011 | $4.33B | $241.77M | 26.39% | 7.98% | 5.59% |
| 2012 | $4.87B | $177.55M | 25.34% | 8.15% | 3.65% |
| 2013 | $5.10B | $226.59M | 26.22% | 9.07% | 4.44% |
| 2014 | $5.46B | $356.38M | 27.49% | 10.81% | 6.53% |
| 2015 | $5.74B | $387.20M | 28.26% | 11.27% | 6.75% |
| 2016 | $6.82B | $115.00M | 30.33% | 9.42% | 1.69% |
| 2017 | $9.70B | $1.31B | 35.05% | 7.41% | 13.49% |
| 2018 | $10.41B | $259.00M | 35.21% | 7.12% | 2.49% |
| 2019 | $11.09B | $191.00M | 34.16% | 7.01% | 1.72% |
| 2020 | $11.36B | $279.00M | 33.97% | 6.44% | 2.46% |
| 2021 | $13.87B | $966.00M | 33.45% | 10.04% | 6.96% |
| 2022 | $14.41B | $1.09B | 34.89% | 12.48% | 7.57% |
| 2023 | $14.98B | $1.36B | 34.96% | 13.19% | 9.06% |
| 2024 | $15.40B | $1.37B | 34.89% | 14.29% | 8.91% |
| 2025 | $16.31B | $1.36B | 26.28% | 14.02% | 8.34% |